Skip to Main content Skip to Navigation
Journal articles

Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials

Abstract : Background: The potential for disease modification of tumour necrosis factor antagonists in ulcerative colitis remains debated. Methods: We searched MEDLINE, the Cochrane Library and EMBASE. Clinical response/remission, mucosal healing, colectomy, disease-related hospitalisations, and adverse events were analysed by the methods of Peto and Der Simonian and Laird. Results: Five trials enrolled 3654 patients (anti-tumour necrosis factor = 2338). Anti-tumour necrosis factor therapy was more effective than placebo to induce and maintain clinical remission, with a number needed to treat of 12 (95% confidence interval [CI], 7-35) and 6 (95% CI, 4-12) for adalimumab and infliximab, respectively. Anti-tumour necrosis factor therapy was more effective than placebo to induce and maintain mucosal healing, with number needed to treat of 9 (95% CI, 5-48), 7 (95% CI, 5-17), 4 (95% CI, 3-6) for adalimumab, golimumab and infliximab, respectively. Only infliximab was associated with a reduced need for colectomy. Both infliximab and adalimumab were associated with less hospitalisations. Anti-tumour necrosis factor therapy did not increase the risk of adverse events. Conclusions: Anti-tumour necrosis factor therapy is more effective than placebo to induce and maintain clinical remission and mucosal healing. Both infliximab and adalimumab are associated with less hospitalisations. Infliximab reduces the need for colectomy. Anti-tumour necrosis factor therapy does not increase the risk of adverse events.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-lorraine.fr/hal-01678993
Contributor : Ngere Ul Connect in order to contact the contributor
Submitted on : Tuesday, January 9, 2018 - 3:43:49 PM
Last modification on : Tuesday, October 13, 2020 - 10:46:44 AM

Identifiers

Collections

Citation

Anthony Lopez, Alexander C. Ford, Jean-Frédéric Colombel, Walter Reinisch, William J. Sandborn, et al.. Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials. Digestive and Liver Disease, WB Saunders, 2015, 47 (5), pp.356 - 364. ⟨10.1016/j.dld.2015.01.148⟩. ⟨hal-01678993⟩

Share

Metrics

Record views

112